Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Diana, Grajales"'
In this study, we conducted a detailed investigation into the time evolution of the probability density within a 1D double-well potential hosting a Bose-Fermi mixture. This system comprised spinless bosons and spin one-half fermions with weak repulsi
Externí odkaz:
http://arxiv.org/abs/2311.02218
Autor:
M. Pilar Valdecantos, Laura Ruiz, Cintia Folgueira, Patricia Rada, Beatriz Gomez-Santos, Maite Solas, Ana B. Hitos, Joss Field, Vera Francisco, Carmen Escalona-Garrido, Sebastián Zagmutt, María Calderon-Dominguez, Paula Mera, Irma Garcia-Martinez, Elsa Maymó-Masip, Diana Grajales, Rosa Alen, Alfonso Mora, Neira Sáinz, Irene Vides-Urrestarazu, Nuria Vilarrasa, José M. Arbones-Mainar, Carlos Zaragoza, María J. Moreno-Aliaga, Patricia Aspichueta, Sonia Fernández-Veledo, Joan Vendrell, Dolors Serra, Laura Herrero, Renate Schreiber, Rudolf Zechner, Guadalupe Sabio, David Hornigold, Cristina M. Rondinone, Lutz Jermutus, Joseph Grimsby, Ángela M. Valverde
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-29 (2024)
Abstract Bariatric surgery is effective for the treatment and remission of obesity and type 2 diabetes, but pharmacological approaches which exert similar metabolic adaptations are needed to avoid post-surgical complications. Here we show how G49, an
Externí odkaz:
https://doaj.org/article/6e46df4151b04affa21678e1243d004d
Publikováno v:
Metabolites, Vol 12, Iss 5, p 443 (2022)
Second-generation antipsychotics (SGAs), in particular, olanzapine and clozapine, have been associated with the development of type 2 diabetes mellitus (T2D) and metabolic syndrome in individuals with schizophrenia. In this context, beta cell dysfunc
Externí odkaz:
https://doaj.org/article/d12cd7fb0c09439ead49148c368f90f6
Autor:
María Vinaixa, Sandra Canelles, África González-Murillo, Vítor Ferreira, Diana Grajales, Santiago Guerra-Cantera, Ana Campillo-Calatayud, Manuel Ramírez-Orellana, Óscar Yanes, Laura M. Frago, Ángela M. Valverde, Vicente Barrios
Publikováno v:
Cells, Vol 10, Iss 8, p 2085 (2021)
Insulin receptor substrate (IRS) 2 is a key mediator of insulin signaling and IRS-2 knockout (IRS2−/−) mice are a preclinical model to study the development of diabetes, as they develop peripheral insulin resistance and beta-cell failure. The dif
Externí odkaz:
https://doaj.org/article/d46ff4296d1f473da67f9a2adc2ddc10
Autor:
Diana Grajales, Patricia Vázquez, Mónica Ruíz-Rosario, Eva Tudurí, Mercedes Mirasierra, Vítor Ferreira, Ana B. Hitos, Dora Koller, Pablo Zubiaur, Juan C. Cigudosa, Francisco Abad-Santos, Mario Vallejo, Iván Quesada, Boaz Tirosh, Gil Leibowitz, Ángela M. Valverde
Publikováno v:
Diabetologia
[Aims/hypothesis]: Second-generation antipsychotic (SGA) drugs have been associated with the development of type 2 diabetes and the metabolic syndrome in patients with schizophrenia. In this study, we aimed to investigate the effects of two different
Publikováno v:
Cells, Vol 8, Iss 11, p 1336 (2019)
Second-generation antipsychotics (SGAs) are the cornerstone of treatment for schizophrenia because of their high clinical efficacy. However, SGA treatment is associated with severe metabolic alterations and body weight gain, which can increase the ri
Externí odkaz:
https://doaj.org/article/17eaa5d196f54afa8f8771a19a36b53b
Autor:
Christian Fernando Montoya, Beatriz Andrea Otálora‑Otálora, Cristina Oñate, Nicolás Niederbacher, Carlos Camero, Adriana Patricia Rojas Moreno, Maria Jose Pinzón, Francisco Javier Muela García, Camila Bernal Forigua, Andrea Valderrama, Alejandra Cañas Arboleda, Litzy Gisella Bermudez, Daniel Mauricio González, Paula Sánchez Velásquez, Diana Grajales, Cathalina Castillo
Publikováno v:
Universitas Médica. 61
El proceso transición epitelio mesénquima (TEM) permite que una célula epitelial de manera temporal, adquiera un fenotipo mesenquimal como respuesta a un estímulo interno o externo. Este proceso se caracteriza por la activación y represión de g
Publikováno v:
Cells
Cells, Vol 8, Iss 11, p 1336 (2019)
Cells, Vol 8, Iss 11, p 1336 (2019)
© 2019 by the authors
Second-generation antipsychotics (SGAs) are the cornerstone of treatment for schizophrenia because of their high clinical efficacy. However, SGA treatment is associated with severe metabolic alterations and body weight gai
Second-generation antipsychotics (SGAs) are the cornerstone of treatment for schizophrenia because of their high clinical efficacy. However, SGA treatment is associated with severe metabolic alterations and body weight gai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::879aa41cfa4feb6e43c42f714c5a791f
http://hdl.handle.net/10261/224050
http://hdl.handle.net/10261/224050
Publikováno v:
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Digital.CSIC. Repositorio Institucional del CSIC
Universidad Autónoma de Madrid
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Digital.CSIC. Repositorio Institucional del CSIC
Schizophrenia is a neuropsychiatric disorder that chronically affects 21 million people worldwide. Second-generation antipsychotics (SGAs) are the cornerstone in the management of schizophrenia. However, despite their efficacy in counteracting both p